Dysregulation of Neuronal Nicotinic Acetylcholine Receptor–Cholesterol Crosstalk in Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a set of complex neurodevelopmental diseases that include impaired social interaction, delayed and disordered language, repetitive or stereotypic behavior, restricted range of interests, and altered sensory processing. The underlying causes of the core symptoms rema...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ana Sofía Vallés, Francisco J. Barrantes
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/c681e5d264994ec8b3bb595ce6be2952
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c681e5d264994ec8b3bb595ce6be2952
record_format dspace
spelling oai:doaj.org-article:c681e5d264994ec8b3bb595ce6be29522021-11-05T16:51:47ZDysregulation of Neuronal Nicotinic Acetylcholine Receptor–Cholesterol Crosstalk in Autism Spectrum Disorder1662-509910.3389/fnmol.2021.744597https://doaj.org/article/c681e5d264994ec8b3bb595ce6be29522021-10-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnmol.2021.744597/fullhttps://doaj.org/toc/1662-5099Autism spectrum disorder (ASD) is a set of complex neurodevelopmental diseases that include impaired social interaction, delayed and disordered language, repetitive or stereotypic behavior, restricted range of interests, and altered sensory processing. The underlying causes of the core symptoms remain unclear, as are the factors that trigger their onset. Given the complexity and heterogeneity of the clinical phenotypes, a constellation of genetic, epigenetic, environmental, and immunological factors may be involved. The lack of appropriate biomarkers for the evaluation of neurodevelopmental disorders makes it difficult to assess the contribution of early alterations in neurochemical processes and neuroanatomical and neurodevelopmental factors to ASD. Abnormalities in the cholinergic system in various regions of the brain and cerebellum are observed in ASD, and recently altered cholesterol metabolism has been implicated at the initial stages of the disease. Given the multiple effects of the neutral lipid cholesterol on the paradigm rapid ligand-gated ion channel, the nicotinic acetylcholine receptor, we explore in this review the possibility that the dysregulation of nicotinic receptor-cholesterol crosstalk plays a role in some of the neurological alterations observed in ASD.Ana Sofía VallésFrancisco J. BarrantesFrontiers Media S.A.articleautism spectrum disordernicotinic receptor (nAChR)cholesterolacetylcholine receptor-cholesterol interactionsperinatal periodNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Molecular Neuroscience, Vol 14 (2021)
institution DOAJ
collection DOAJ
language EN
topic autism spectrum disorder
nicotinic receptor (nAChR)
cholesterol
acetylcholine receptor-cholesterol interactions
perinatal period
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle autism spectrum disorder
nicotinic receptor (nAChR)
cholesterol
acetylcholine receptor-cholesterol interactions
perinatal period
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Ana Sofía Vallés
Francisco J. Barrantes
Dysregulation of Neuronal Nicotinic Acetylcholine Receptor–Cholesterol Crosstalk in Autism Spectrum Disorder
description Autism spectrum disorder (ASD) is a set of complex neurodevelopmental diseases that include impaired social interaction, delayed and disordered language, repetitive or stereotypic behavior, restricted range of interests, and altered sensory processing. The underlying causes of the core symptoms remain unclear, as are the factors that trigger their onset. Given the complexity and heterogeneity of the clinical phenotypes, a constellation of genetic, epigenetic, environmental, and immunological factors may be involved. The lack of appropriate biomarkers for the evaluation of neurodevelopmental disorders makes it difficult to assess the contribution of early alterations in neurochemical processes and neuroanatomical and neurodevelopmental factors to ASD. Abnormalities in the cholinergic system in various regions of the brain and cerebellum are observed in ASD, and recently altered cholesterol metabolism has been implicated at the initial stages of the disease. Given the multiple effects of the neutral lipid cholesterol on the paradigm rapid ligand-gated ion channel, the nicotinic acetylcholine receptor, we explore in this review the possibility that the dysregulation of nicotinic receptor-cholesterol crosstalk plays a role in some of the neurological alterations observed in ASD.
format article
author Ana Sofía Vallés
Francisco J. Barrantes
author_facet Ana Sofía Vallés
Francisco J. Barrantes
author_sort Ana Sofía Vallés
title Dysregulation of Neuronal Nicotinic Acetylcholine Receptor–Cholesterol Crosstalk in Autism Spectrum Disorder
title_short Dysregulation of Neuronal Nicotinic Acetylcholine Receptor–Cholesterol Crosstalk in Autism Spectrum Disorder
title_full Dysregulation of Neuronal Nicotinic Acetylcholine Receptor–Cholesterol Crosstalk in Autism Spectrum Disorder
title_fullStr Dysregulation of Neuronal Nicotinic Acetylcholine Receptor–Cholesterol Crosstalk in Autism Spectrum Disorder
title_full_unstemmed Dysregulation of Neuronal Nicotinic Acetylcholine Receptor–Cholesterol Crosstalk in Autism Spectrum Disorder
title_sort dysregulation of neuronal nicotinic acetylcholine receptor–cholesterol crosstalk in autism spectrum disorder
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/c681e5d264994ec8b3bb595ce6be2952
work_keys_str_mv AT anasofiavalles dysregulationofneuronalnicotinicacetylcholinereceptorcholesterolcrosstalkinautismspectrumdisorder
AT franciscojbarrantes dysregulationofneuronalnicotinicacetylcholinereceptorcholesterolcrosstalkinautismspectrumdisorder
_version_ 1718444125924098048